Letter to the Editor Regarding "Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination" by Albertson et al. 2024
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-04-01
|
| Series: | Infectious Diseases and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40121-025-01136-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849734110903271424 |
|---|---|
| author | Ivan Pourmir Adrian Alanis Niccolò Clemente |
| author_facet | Ivan Pourmir Adrian Alanis Niccolò Clemente |
| author_sort | Ivan Pourmir |
| collection | DOAJ |
| format | Article |
| id | doaj-art-16f876a3c40946b18582d0aec748e6b4 |
| institution | DOAJ |
| issn | 2193-8229 2193-6382 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Adis, Springer Healthcare |
| record_format | Article |
| series | Infectious Diseases and Therapy |
| spelling | doaj-art-16f876a3c40946b18582d0aec748e6b42025-08-20T03:07:54ZengAdis, Springer HealthcareInfectious Diseases and Therapy2193-82292193-63822025-04-011451133113610.1007/s40121-025-01136-zLetter to the Editor Regarding "Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination" by Albertson et al. 2024Ivan Pourmir0Adrian Alanis1Niccolò Clemente2Paris Research Cardiovascular Center, Université Paris Cité, INSERM U970Ecole Doctorale Pierre Louis de Santé Publique, Université Paris CitéHeart and Diabetes Center NRW University Hospital (Ruhr University Bochum) Center for Congenital Heart Defects, Pediatric Clinic, St. Josef-Hospital Clinic for Pediatric and Adolescent Medicinehttps://doi.org/10.1007/s40121-025-01136-zBNT162b2COVID-19 vaccinesSafetyMyocarditisMyocardial injuryTroponin I |
| spellingShingle | Ivan Pourmir Adrian Alanis Niccolò Clemente Letter to the Editor Regarding "Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination" by Albertson et al. 2024 Infectious Diseases and Therapy BNT162b2 COVID-19 vaccines Safety Myocarditis Myocardial injury Troponin I |
| title | Letter to the Editor Regarding "Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination" by Albertson et al. 2024 |
| title_full | Letter to the Editor Regarding "Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination" by Albertson et al. 2024 |
| title_fullStr | Letter to the Editor Regarding "Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination" by Albertson et al. 2024 |
| title_full_unstemmed | Letter to the Editor Regarding "Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination" by Albertson et al. 2024 |
| title_short | Letter to the Editor Regarding "Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination" by Albertson et al. 2024 |
| title_sort | letter to the editor regarding serum troponin i assessments in 5 to 30 year olds after bnt162b2 vaccination by albertson et al 2024 |
| topic | BNT162b2 COVID-19 vaccines Safety Myocarditis Myocardial injury Troponin I |
| url | https://doi.org/10.1007/s40121-025-01136-z |
| work_keys_str_mv | AT ivanpourmir lettertotheeditorregardingserumtroponiniassessmentsin5to30yearoldsafterbnt162b2vaccinationbyalbertsonetal2024 AT adrianalanis lettertotheeditorregardingserumtroponiniassessmentsin5to30yearoldsafterbnt162b2vaccinationbyalbertsonetal2024 AT niccoloclemente lettertotheeditorregardingserumtroponiniassessmentsin5to30yearoldsafterbnt162b2vaccinationbyalbertsonetal2024 |